Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Alzex Neuropharma Inc. Stock Analysis TRRI
United States Materials Nano Cap Trinity Resources, Inc. engages in the exploration and development of natural resource interests. The company is headquartered in Henderson, Nevada. The company went IPO on 2001-07-11. The firm is engaged in research and development targeting treatments of brain diseases. The company is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimer’s Disease but can be applied to other neurological diseases due to its platform technology.
Read More Alzex Neuropharma Inc (TRRI) Chart
Key Statistics of Alzex Neuropharma Inc (TRRI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
333.00P/E Ratio (TTM)
-52 Week Range
Market Cap
752.60Avg. Volume
333.00Dividend Yield
-Financial Metrics & Statements of Alzex Neuropharma Inc (TRRI)
FAQ's for Alzex Neuropharma Inc (TRRI)
- According to Musaffa’s Shariah screening methodology, Alzex Neuropharma Inc (TRRI) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Alzex Neuropharma Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Alzex Neuropharma Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Alzex Neuropharma Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Alzex Neuropharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Alzex Neuropharma Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.